FINWIRES · TerminalLIVE
FINWIRES

ApicHope Pharmaceutical Unit Gets China Nod for Hemostatic Drug

By

ApicHope Pharmaceutical (SHE:300723) unit Guangzhou Yipinhong Pharmaceutical obtained drug registration from China's medical products regulator for aminocaproic acid injection.

The drug is used to treat various bleeding caused by hyperfibrinolysis, according to a Friday fling with the Shenzhen bourse.

The approval is valid until May 2031.

Shares of the pharmaceutical company were up 3% Friday.

Related Articles